2024 ASTRO Coding and Coverage Seminar - Brachytherapy and Radiopharmaceuticals
Topics Included:
1. Brachytherapy
Participants will learn about the radiation therapy modality of brachytherapy. Codes specific to this modality are addressed. ASTRO’s Brachytherapy Model Policy is reviewed in detail.
2. Radiopharmaceuticals
Participants will learn about the increasing use of radiopharmaceuticals and their current code development.
This activity was originally presented and recorded at the 2024 ASTRO Coding and Coverage Seminar.
This activity is available from January 27, 2025, through 11:59 p.m. Eastern time on March 31, 2025.
Target Audience
This activity is designed to meet the interests of radiation oncologists, physicists, radiation therapists, radiation dosimetrists, practice administrators, certified coders and professional coders.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Explain the complexities associated with brachytherapy.
- Explain the role of the Nuclear Regulatory Commission and other agencies involved with brachytherapy treatments due to the use of radioactive isotopes.
- Identify differences in LDR and HDR brachytherapy and how to correctly code the treatments.
- Navigate a combined brachytherapy/external beam RT treatment plan with correct coding.
- Explain the complexities associated with the use of radiopharmaceuticals.
- Identify and use the codes associated with radiopharmaceuticals.
- Correctly code for radiopharmaceuticals and understand the complexities associated with these codes.
- Gain insight into possible coding changes coming down the line for radiopharmaceuticals.
The person(s) above served as the developer(s) of this activity. Additionally, the Education Committee had control over the content of this activity. All relevant financial relationships have been mitigated.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Available Credit
- 0.75 AMA PRA Category 1 Credit™The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 0.75 Certificate of AttendanceThis activity was designated for 0.75 AMA PRA Category 1 Credit™.
Price
Course Fees:
ASTRO members must log in to the ASTRO website to view and receive the member rate.
- Nonmember: $100
- Member: $75
- Member-in-Training: $35*
- Student/Graduate Student/PGY-1 Member: $35*
*Residents and Students can join ASTRO for free to receive the discounted rates.
Membership Application: https://www.astro.org/MyAstro/MyProfile/Membership-Application
Policies:
No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the activity by the expiration date.
Participants using ASTRO Academy activities to satisfy the requirement of a Continuing Certification (MOC) program should verify the credit number and type and availability dates of any activity before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased activities that do not align with their MOC requirement.
The activity and its materials will only be available on the ASTRO website until March 31, 2025 regardless of purchase date. At the expiration of the activity, participants will no longer have access to the activity or its materials. ASTRO reserves the right to remove an activity before its expiration date.
Required Hardware/software
One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.